The Effect of a Nutritional Supplement Product Containing Cactus Fruit Juice (Nopalea) on C-Reactive Protein, a Blood-Born Marker of Inflammation



Status:Recruiting
Healthy:No
Age Range:35 - 75
Updated:2/7/2015
Start Date:May 2013
Contact:Mark E Mattie, MD, Ph.D.
Email:mmattie@bridgeport.edu
Phone:203-576-4127

Use our guide to learn which trials are right for you!

Nopalea Clinical Trial

This study has been developed to investigate the anti-inflammatory effects of a commercial
product (Nopalea) containing Prickly Pear Cactus Fruit Juice in healthy adults. The research
method employs a double blind, placebo controlled, and time-series (repeat measures) design
with high-sensitivity C-Reactive Protein (HS-CRP) serving as a marker for inflammation -
testing for levels of CRP at time points: baseline (pre-test), 8 weeks (60 days) and 12
weeks (90 days). The final time point (i.e., 12 weeks) will serve as the post-test. It is
expected that baseline CRP levels in healthy participants will decline.


Live within traveling distance of the research center. Access to a telephone in their
residence. Between 35 and 75 years of age Not currently ingesting Nopalea Not pregnant,
planning to become pregnant, or nursing a child Not currently taking anti-inflammatory
medications Medically stable - i.e. no recent major change in the last 3 weeks of
prescription or non- prescription medication Not diagnosed with Type 1 Diabetes Not
diagnosed with depression Not diagnosed with an acquired or congenital immune system
deficiency
We found this trial at
1
site
Scottsdale, Arizona 06473
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials